Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you – page 19

recruiting
3 973
countries
28
conditions
2 104

464 trials match your criteria

HER2 positive breast cancer

Not recruiting

Study of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan

Cardiac amyloidosis

Not recruiting

Study of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran

Dementia Alzheimer's type

Not recruiting

Study on the Effects of Semaglutide in Patients with Early Alzheimer's Disease

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide

Crohn's disease

Not recruiting

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide

Amyotrophic lateral sclerosis

Not recruiting

Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Phenylbutyrate

Breast cancer

Not recruiting

Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine

Metastatic renal cell carcinoma

Not recruiting

Study of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib

Systemic scleroderma

Not recruiting

Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms

Investigational
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:BI 685509

Systemic lupus erythematosus

Not recruiting

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.